You are here:

Our 2010/11 Achievements


  • We maintained strong blood stock levels through our dedicated collection teams and everyone who supports them, plus well-planned marketing activity.

  • We collected nearly 2 million blood donations from nearly 1.4 million donors from teams operating across England and North Wales.

  • Blood collection productivity increased again this year and has grown by 22% over the past three years.

  • We carried out 3,740 transplants in the UK - the sixth year on year growth in the number of transplants. And the number of deceased organ donors increase to over 1,000 - a new record. Consent rates for organ donation following brain death also continued to rise from 61% of families approached about donation in 2009/10 to 65% in 2010/11.

  • We delivered £30m in savings to the NHS to reinvest in frontline patient care through a successful three-year change programme. This saw us consolidate some of our manufacturing and testing departments to reduce the cost of a unit of blood from £140 in 2008/09 to just under £125 by 2010/11.

  • We improved security of blood supply, reducing the number of days where stock levels have fallen below acceptable levels from 87 in 2007/8 to only two in 2010/11.

  • We have increased productivity in testing by 35% and in processing by 50% since April 2008. This means we are on track to achieve European top quartile performance levels in both areas by the end of 2011/12.

  • We improved blood safety by introducing bacterial screening and improving the way we assess new tests.

  • We reduced incidences of fainting and rebleeding which improved blood donor safety and satisfaction.

  • We also reduced the number of non-compliances from regulatory inspections.

  • We delivered the first UK-wide 10 year stem cell transplant strategy to all four governments. And we have already started implementing findings through high resolution stem cell testing to deliver better patient outcomes.